Company Filing History:
4 out of 2,945 
1 out of 135 
1 out of 832,880 Years Active: 2017-2024
Title: Qi An - Innovator in Antibody Therapeutics
Introduction
Qi An is a prominent inventor based in Nashua, NH (US), known for his significant contributions to the field of antibody therapeutics. With a total of six patents to his name, he has made remarkable strides in enhancing immune responses and developing treatments for various cancers.
Latest Patents
Among his latest patents is the invention of anti-PD-L1 antibodies and their uses. This application focuses on enhancing T-cell function to upregulate cell-mediated immune responses, particularly for treating T cell dysfunctional disorders, including tumor immunity and cancer. Another notable patent is for a monoclonal antibody directed to FGFR1. This invention pertains to antibodies that specifically bind to and neutralize human, macaque, and mouse forms of FGFR1 with high affinity. It also includes nucleic acids encoding these antibodies, vectors for their expression, and host cells for their production. The use of these antibodies is aimed at the diagnosis and treatment of cancers.
Career Highlights
Qi An has worked with notable companies, including Merck Patent GmbH, where he has furthered his research and development in the field of antibody therapeutics. His work has contributed to advancements in cancer treatment and immune response enhancement.
Collaborations
Some of his coworkers include Christel Iffland and Horacio Gabriel Nastri, who have collaborated with him on various projects related to his patents and innovations.
Conclusion
Qi An's innovative work in the field of antibody therapeutics has the potential to significantly impact cancer treatment and immune response enhancement. His contributions through his patents reflect a commitment to advancing medical science and improving patient outcomes.